POLICY / RESEARCH
Research Use Policy
Effective August 16, 2026 · Current release
Qualification
Submitting an application creates a PENDING review only. First Standard may request business-identity or nonclinical-purpose evidence, reject an application, or leave a product unavailable. APPROVED account status alone cannot activate a product or transaction.
Prohibited submissions and representations
Do not submit patient information or request dosing, administration, diagnosis, treatment, prescribing, dispensing, or human-use support. Do not represent a catalog identity, QR route, independent test, or quality document as proof of sale authority, clinical suitability, or availability.
Verification before payment
Provide a brief description of the nonclinical tests and a lab, investigator or project reference. You may request private verification when public documentation is unavailable. We independently review the recipient’s ongoing research activity and the intended use of the specific products, quantities and delivery location before enabling payment. A declaration alone does not qualify a purchase.
Unused research materials
If an investigation ends or is discontinued, contact support@firststandardpeptides.com for written return or alternative-disposition instructions for unused investigational materials. Do not transfer them for human use or send a return without authorization. We keep the relevant shipment and disposition records for at least two years after shipment.
Separate records
Research and Community audiences remain separate. A Research record never becomes a consumer or human-use record through naming, packaging, testing, customer status, or a QR link.